Abstract
The binding characteristics and quantitation of the recently reported fetal steroid binding protein (FSBP) cannot be determined on unpurified samples; an immunoassay was therefore desirable. The protein was purified to homogeneity in order to raise a highly specific polyclonal antibody. An enzyme-linked immunosorbent assay applicable to unpurified samples was developed. Intra- and inter-assay coefficients of variation are 8.0% and 9.2% respectively; there is a sensitivity of 30 fmol FSBP per well, and there is no cross-reactivity with other binding proteins. Results obtained with the assay correlate with the more complex ligand binding assay (r = 0.85; p less than 0.02). Measurement of sera showed that FSBP levels are higher in women than in men (51.2 +/- 10.62 nM; 41.2 +/- 13.65 respectively; p less than 0.05) and are elevated in cirrhotic women (66.4 +/- 18.67; p less than 0.05) and in males with hepatocellular carcinoma (62.2 +/- 13.05; p less than 0.002). Use of the enzyme-linked immunosorbent assay confirmed the identity of FSBP separate from sex hormone binding globulin.
Original language | English |
---|---|
Pages (from-to) | 31-8 |
Number of pages | 8 |
Journal | Steroids |
Volume | 45 |
Issue number | 1 |
Publication status | Published - Jan 1985 |
Keywords
- Carcinoma, Hepatocellular
- Carrier Proteins
- Enzyme-Linked Immunosorbent Assay
- Female
- Fetus
- Humans
- Liver Cirrhosis
- Liver Neoplasms
- Male
- Pregnancy
- Quality Control
- Sex Hormone-Binding Globulin
- Steroids